Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
Crossref DOI link: https://doi.org/10.1186/s12891-017-1577-2
Published Online: 2017-05-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Tsan-Wen
Wang, Chao-Jan
Shih, Hsin-Nung
Chang, Yuhan
Huang, Kuo-Chin
Peng, Kuo-Ti
Lee, Mel S.
Funding for this research was provided by:
Novartis Foundation (CZOL446HTW07T study)
